Listen to experienced IP professionals discuss how best to right size your IP spending to strike the right balance between reducing IP costs and building your company’s IP position and technology value. This panel discusses how the changing IP regulatory environment may impact these decisions.
Moderator: John T. Gutkoski
Panelists:
David Cerveny, Vice President Intellectual Property and General Counsel, ConforMIS, Inc.
Wendy Rieder, General Counsel and Vice President Intellectual Property and Legal Affairs, Synta Pharmaceuticals Corp.
Steve Tannenbaum, Executive Vice President and Chief Financial Officer, Collegium Pharmaceutical, Inc.
Related Insights
April 29, 2026
Foley Viewpoints
Tax the Rich: Additional States Considering and Enacting Taxes Targeting High-Net-Worth Individuals
As predicted in the March 16, 2026, Foley Blog, a number of states recently moved to enact or propose income taxes aimed at individuals…
April 29, 2026
Innovative Technology Insights
From Static Compliance to Living Compliance: How Agentic AI Can Make Health Care Operations Safer
This piece was written in collaboration with Sam De Brouwer, co‑founder and CEO of XY.AI, and Lamara de Brouwer, co‑founder and CTO of…
April 29, 2026
Health Care Law Today Podcast
Episode 38: Let’s Talk Compliance: Not All wRVU’s are Created Equal (Part 1)
In this episode, Jana Kolarik, a partner in Foley’s Health Care Practice Group and Angie Caldwell, CFO and managing principal of PYA, discuss the importance of work relative value units (WRVUs) and fair market value (FMV) under the Stark Law and what this can mean for how health care organizations pay their physicians.